Delcath Systems, Inc. - Common Stock (DCTH)

Delcath Systems Inc is a medical technology company focused on the development and commercialization of innovative therapeutic systems for the treatment of cancer

The company's primary product is a specialized delivery system designed to administer high doses of chemotherapy directly to tumors while reducing systemic exposure and associated side effects. Through its proprietary techniques, Delcath aims to improve treatment outcomes for patients suffering from various types of cancer, particularly liver cancers, by enhancing the efficacy and safety of cancer therapies. The company is dedicated to advancing its technologies and expanding its clinical applications to better serve oncologists and patients in the fight against cancer.